$29.030
+0.261 (+0.90%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AMLX Prediction & Forecast by Similar Chart Analysis
Alphio's AMLX stock price prediction model matches the current Amylyx Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.88 (-0.50%). The 1-week path is $27.23 (-6.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Amylyx Pharmaceuticals, Inc. Stock?
Amylyx Pharmaceuticals Inc is currently not a strong buy due to its recent price decline and negative financial performance, despite a promising future with a current price of $26.34 and a forward P/E of 2.77. The stock has dropped 6.40% over the last five days and insiders have increased selling by 2291.45%, indicating potential caution. However, analyst targets suggest significant upside, with Guggenheim raising their target to $57, which reflects a potential increase of over 116% from the current price. The main risk is the company’s ongoing negative net income, which was -43,423,000 in Q2 2026, highlighting financial instability that could affect future performance.
AMLX stock price ended at $29.03 on Wednesday, after rising +0.90%
Amylyx Pharmaceuticals, Inc. (AMLX) last closed at $29.03, gaining +0.90%. These facts feed the 1-day and 1-week AMLX price prediction above.
Forecast Drivers
Amylyx Pharmaceuticals, Inc. (AMLX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches AMLX, ranked by similarity.
Seasonality analysis for AMLX
Historically the probability of a positive October return for AMLX is 62.30%. June offers the highest probability of a positive month at 68.33%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.